PET with Fluorodeoxyglucose F 18/Computed Tomography as a Staging Tool in Multiple Myeloma

被引：6
|
作者：
Seval, Guldane Cengiz [1 ]
Ozkan, Elgin [2 ]
Beksac, Meral [1 ]
机构：
[1] Ankara Univ, Sch Med, Cebeci Res & Applicat Hosp, Dept Hematol, TR-06590 Mamak, Amkara, Turkey
[2] Ankara Univ, Sch Med, Cebeci Res & Applicat Hosp, Dept Nucl Med, TR-06590 Mamak, Amkara, Turkey
来源：
PET CLINICS | 2019年 / 14卷 / 03期
关键词：
Multiple myeloma; Staging; PET/CT; POSITRON-EMISSION-TOMOGRAPHY; BONE-MARROW ANGIOGENESIS; F-18-FDG PET/CT; FDG-PET/CT; SOLITARY PLASMACYTOMA; IMAGING TECHNIQUES; MONOCLONAL GAMMOPATHY; MANAGEMENT; GUIDELINES; DIAGNOSIS;
D O I：
10.1016/j.cpet.2019.03.009
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
In the past decade novel treatment options have dramatically prolonged the survival of patients with multiple myeloma. PET combined with computed tomography (CT) is a sensitive and reliable functional imaging tool that enables diagnosis and assessment of response to chemotherapy/radiotherapy, and combines high sensitivity in identifying both lytic lesions and extramedullary soft-tissue masses with the ability to provide reliable prognostic information in the management of patients with myeloma. This review comprises a comprehensive overview of PET with fluorodeoxyglucose F 18/CT imaging in combination with other convenient imaging procedures, and attempts at standardization with emphasis on post-therapy findings in patients with myeloma.
引用
收藏
页码：369 / +
页数：14
相关论文
共 50 条
  • [41] Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT)
    Katherine Cameron
    Sivan Golan
    William Simpson
    Steven Peti
    Sasan Roayaie
    Daniel Labow
    Lale Kostakoglu
    Abdominal Imaging, 2011, 36 : 463 - 471
  • [42] F-18-fluorodeoxyglucose-positron-emission tomography/computed tomography staging of mucinous tubular and spindle cell carcinoma of the kidney
    Ozturk, Hakan
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2015, 30 (01): : 68 - 71
  • [43] Initial staging and treatment monitoring of right atrial sarcoma with F-18 fluorodeoxyglucose positron emission tomography/computed tomography
    Manohar, Kuruva
    Kashyap, Raghava
    Bhattacharya, Anish
    Mittal, Bhagwant Rai
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2013, 28 (03): : 188 - 189
  • [44] The Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Staging of Primary Extranodal Head and Neck Lymphomas
    Schrepfer, Thomas
    Haerle, Stephan K.
    Strobel, Klaus
    Schaefer, Niklaus
    Haelg, Roger A.
    Huber, Gerhard F.
    LARYNGOSCOPE, 2010, 120 (05): : 937 - 944
  • [45] Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT)
    Cameron, Katherine
    Golan, Sivan
    Simpson, William
    Peti, Steven
    Roayaie, Sasan
    Labow, Daniel
    Kostakoglu, Lale
    ABDOMINAL IMAGING, 2011, 36 (04): : 463 - 471
  • [46] Fluorodeoxyglucose-avid focal lesions and extramedullary disease on 18F-FDG PET/computed tomography predict the outcomes of newly diagnosed symptomatic multiple myeloma patients
    Zhong, Xiao
    Diao, Wei
    Zhao, Chunyan
    Jia, Zhiyun
    NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (09) : 950 - 958
  • [47] Preoperative staging of clinically node-negative esophageal cancer by the combination of 18F-fluorodeoxyglucose positron emission tomography and computed tomography (FDG–PET/CT)
    Masahiko Yano
    Masaaki Motoori
    Koji Tanaka
    Kentaro Kishi
    Yoshiyuki Fujiwara
    Tatsushi Shingai
    Kunihito Gotoh
    Hidenori Takahashi
    Shingo Noura
    Terumasa Yamada
    Masayuki Ohue
    Hiroaki Ohigashi
    Osamu Ishikawa
    Esophagus, 2012, 9 : 210 - 216
  • [48] Role of F-18-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Scan in Primary Staging of Breast Cancer Compared to Conventional Staging
    Akepati, Naveen Kumar Reddy
    Abubakar, Zakir Ali
    Bikkina, Prathyusha
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2018, 33 (03): : 190 - 193
  • [49] Comparison between fluorine-18 fluorodeoxyglucose PET/CT (PET) and contrast enhancement Computed Tomography (ceCT) for staging in esophageal cancer
    Panareo, Stefano
    Cittanti, Corrado
    Santi, Ivan
    Peterle, Chiara
    de Cristofaro, Valentina
    Feggi, Luciano
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [50] Preoperative staging of F-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) in patients with gastric cancer
    Kim, J.
    Choi, S.
    Lee, M.
    Hyun, I
    Hur, Y.
    Kim, H.
    Shin, Y.
    Shin, S.
    Kim, Y.
    Kim, C.
    ANNALS OF ONCOLOGY, 2008, 19 : 44 - 45
12345